Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Aquestive Therapeutics, Inc. (AQST)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
14 Jun 2022
Boyd Peter E.
SVP-Bus. Process & Info. Tech., Officer
Aquestive Therapeutics, Inc.
(AQST)
59,532
+9%
5,000
$0.81
$4,050.00
BUY
8 Jun 2022
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
882,871
+5%
45,871
$0.96
$44,036.16
BUY
8 Jun 2022
BRAENDER LORI J
General Counsel, Officer
Aquestive Therapeutics, Inc.
(AQST)
38,761
+55%
13,761
$0.96
$13,210.56
BUY
8 Jun 2022
Barber Daniel
Chief Executive Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
193,702
+89%
91,743
$0.96
$88,073.28
BUY
8 Jun 2022
Boyd Peter E.
SVP-Bus. Process & Info. Tech., Officer
Aquestive Therapeutics, Inc.
(AQST)
54,532
+4%
2,293
$0.96
$2,201.28
SELL
9 Feb 2021
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
837,000
-4%
35,000
$6.75
$236,250.00
SELL
8 Feb 2021
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
872,000
-4%
40,792
$6.50
$265,148.00
SELL
18 Aug 2020
Maxwell John T.
SVP-Chief Financial Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
150,614
-1%
3,000
$8.00
$24,000.00
SELL
4 Jun 2020
Kendall Keith J
CEO and President, Director, Officer
Aquestive Therapeutics, Inc.
(AQST)
638,964
-7%
50,000
$5.11
$255,310.02
SELL
8 May 2020
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
902,113
-4%
40,000
$5.00
$200,000.00
SELL
29 Apr 2020
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
1,022,113
-3%
40,000
$4.50
$180,000.00
SELL
14 Apr 2020
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
942,113
-7%
80,000
$3.85
$308,000.00
BUY
16 Mar 2020
BRAENDER LORI J
SVP, General Counsel, Officer
Aquestive Therapeutics, Inc.
(AQST)
25,000
+127%
14,000
$1.54
$21,624.40
BUY
16 Mar 2020
Boyd Peter E.
SVP-Bus. Process & Info. Tech., Officer
Aquestive Therapeutics, Inc.
(AQST)
52,239
+3%
2,000
$1.50
$3,000.00
BUY
27 Aug 2019
Barber Daniel
SVP-Chief Operating Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
101,959
+2%
2,000
$3.99
$7,980.00
BUY
19 Aug 2019
Scibetta James S
Director
Aquestive Therapeutics, Inc.
(AQST)
31,635
+265%
22,971
$3.79
$86,977.06
BUY
12 Aug 2019
Boyd Peter E.
SVP-Bus. Process & Info. Tech., Officer
Aquestive Therapeutics, Inc.
(AQST)
50,239
+1%
600
$3.81
$2,286.00
BUY
9 Aug 2019
BRAENDER LORI J
SVP, General Counsel, Officer
Aquestive Therapeutics, Inc.
(AQST)
11,000
+1000%
10,000
$4.07
$40,747.00
BUY
9 Aug 2019
Kendall Keith J
CEO and President, Director, Officer
Aquestive Therapeutics, Inc.
(AQST)
653,581
+1%
8,000
$3.87
$30,987.00
BUY
9 Aug 2019
Wood Theresa
SVP-HR and Org. Development, Officer
Aquestive Therapeutics, Inc.
(AQST)
80,765
+1%
1,000
$3.99
$3,990.00
BUY
10 Dec 2018
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
1,019,624
+0%
1,000
$7.78
$7,780.00
BUY
10 Dec 2018
Barber Daniel
SVP-Chief Strategy/Dev Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
99,959
+1%
1,000
$8.00
$8,000.00
BUY
6 Dec 2018
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
1,018,624
+0%
2,000
$8.69
$17,380.00
BUY
6 Dec 2018
Maxwell John T.
SVP-Chief Financial Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
153,614
+3%
5,000
$8.87
$44,350.00
BUY
27 Nov 2018
BRAENDER LORI J
General Counsel, Officer
Aquestive Therapeutics, Inc.
(AQST)
1,000
+100%
1,000
$10.57
$10,570.00
BUY
27 Nov 2018
Kendall Keith J
CEO and President, Director, Officer
Aquestive Therapeutics, Inc.
(AQST)
621,139
+0%
1,000
$9.87
$9,870.00
BUY
26 Nov 2018
Wood Theresa
SVP-HR and Org. Development, Officer
Aquestive Therapeutics, Inc.
(AQST)
79,765
+0%
500
$10.34
$5,170.00
BUY
21 Nov 2018
Schobel Alexander Mark
Chief Innovation/Tech Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
1,009,229
+0%
1,000
$10.25
$10,250.00
BUY
21 Nov 2018
Marshall Ken W.
Commercial Leader, Officer
Aquestive Therapeutics, Inc.
(AQST)
1,445
+100%
1,445
$10.15
$14,666.75
BUY
21 Nov 2018
Maxwell John T.
SVP-Chief Financial Officer, Officer
Aquestive Therapeutics, Inc.
(AQST)
148,614
+7%
10,000
$9.80
$98,000.00
BUY
21 Nov 2018
Kendall Keith J
CEO and President, Director, Officer
Aquestive Therapeutics, Inc.
(AQST)
620,139
+1%
7,950
$10.10
$80,325.00
BUY
21 Nov 2018
Boyd Peter E.
SVP-Operations/Value Delivery, Officer
Aquestive Therapeutics, Inc.
(AQST)
49,639
+0%
200
$9.98
$1,996.00
BUY
24 Jul 2018
BRATTON DOUGLAS K
Director, 10% Owner
Aquestive Therapeutics, Inc.
(AQST)
165,000
+100%
165,000
$15.00
$2,475,000.00
Home